| 000 | 01651 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515012640.0 | ||
| 264 | 0 | _c20060425 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a0364-5134 | ||
| 024 | 7 |
_a10.1002/ana.20759 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKorman, Stanley H | |
| 245 | 0 | 0 |
_aTreatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation. _h[electronic resource] |
| 260 |
_bAnnals of neurology _cFeb 2006 |
||
| 300 |
_a411-5 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAldehydes _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aAmino Acid Oxidoreductases _xmetabolism |
| 650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
| 650 | 0 | 4 |
_aDNA Mutational Analysis _xmethods |
| 650 | 0 | 4 |
_aEpoxy Compounds _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlycine Dehydrogenase _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycinemia, Nonketotic _xcerebrospinal fluid |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aKetamine _xtherapeutic use |
| 650 | 0 | 4 |
_aMultienzyme Complexes _xmetabolism |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSodium Benzoate _xtherapeutic use |
| 650 | 0 | 4 |
_aTransferases _xmetabolism |
| 700 | 1 | _aWexler, Isaiah D | |
| 700 | 1 | _aGutman, Alisa | |
| 700 | 1 | _aRolland, Marie-Odile | |
| 700 | 1 | _aKanno, Junko | |
| 700 | 1 | _aKure, Shigeo | |
| 773 | 0 |
_tAnnals of neurology _gvol. 59 _gno. 2 _gp. 411-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ana.20759 _zAvailable from publisher's website |
| 999 |
_c16021759 _d16021759 |
||